Cargando…

Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy

Assessments of patient-reported outcomes and health-related quality of life in cancer clinical trials have been increasingly emphasized recently because patient and public involvement in cancer treatment development has been promoted by regulatory authorities and academic societies. To assess patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishiki, Hiroto, Kikawa, Yuichiro, Terada, Mitsumi, Mizusawa, Junki, Honda, Michitaka, Iwatani, Tsuguo, Mizutani, Tomonori, Mori, Keita, Nakamura, Naoki, Miyaji, Tempei, Yamaguchi, Takuhiro, Ando, Masahiko, Nakamura, Kenichi, Fukuda, Haruhiko, Kiyota, Naomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Review Article (Invited)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991489/ https://www.ncbi.nlm.nih.gov/pubmed/36702740 http://dx.doi.org/10.1093/jjco/hyad007

Ejemplares similares

Geriatric Research Policy: Japan Clinical Oncology Group (JCOG) policy
por: Mizutani, Tomonori, et al.
Publicado: (2019)

Prospective observational study estimating willingness-to-pay for breast cancer treatments through contingent valuation method in Japanese breast cancer patients (JCOG1709A)
por: Iwatani, Tsuguo, et al.
Publicado: (2021)

Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)
por: Tahara, Makoto, et al.
Publicado: (2015)

Results from a 1-day workshop on the assessment of quality of life in cancer patients: a joint initiative of the Japan Clinical Oncology Group and the European Organisation for Research and Treatment of Cancer
por: Terada, Mitsumi, et al.
Publicado: (2020)

Risk Factors for Esophageal Fistula Associated With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer: A Supplementary Analysis of JCOG0303
por: Tsushima, Takahiro, et al.
Publicado: (2016)

Total neoadjuvant therapy followed by a watch-and-wait strategy for patients with rectal cancer (TOWARd): protocol for single-arm phase II/III confirmatory trial (JCOG2010)
por: Hashimoto, Tadayoshi, et al.
Publicado: (2023)

Prospective evaluation of Ki-67 system in histological grading of soft tissue sarcomas in the Japan Clinical Oncology Group Study JCOG0304
por: Tanaka, Kazuhiro, et al.
Publicado: (2016)

Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001)
por: Kawakami, Takeshi, et al.
Publicado: (2022)

Utility of circulating tumour DNA for prognosis and prediction of therapeutic effect in locally recurrent rectal cancer: study protocol for a multi-institutional, prospective observational study (JCOG1801A1, CAP-LR study)
por: Hashimoto, Tadayoshi, et al.
Publicado: (2023)

Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study
por: Matsuoka, Hiromichi, et al.
Publicado: (2017)

An integrated analysis of hyponatremia in cancer patients receiving platinum-based or nonplatinum-based chemotherapy in clinical trials (JCOG1405-A)
por: Ezoe, Yasumasa, et al.
Publicado: (2017)

Institutional variation in survival and morbidity in laparoscopic surgery for colon cancer: From the data of a randomized controlled trial comparing open and laparoscopic surgery (JCOG0404)
por: Katayama, Hiroshi, et al.
Publicado: (2021)

Confirmatory trial of non-amputative digit preservation surgery for subungual melanoma: Japan Clinical Oncology Group study (JCOG1602, J-NAIL study protocol)
por: Tanaka, Kiyo, et al.
Publicado: (2019)

Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807)
por: Hironaka, Shuichi, et al.
Publicado: (2014)

Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502: a prospective multicenter study
por: Nozaki, Isao, et al.
Publicado: (2015)

Inter-institutional heterogeneity in outcomes of chemotherapy for metastatic gastric cancer: correlative study in the JCOG9912 phase III trial
por: Kurokawa, Y, et al.
Publicado: (2016)

Erratum to: Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502: a prospective multicenter study
por: Nozaki, Isao, et al.
Publicado: (2015)

Non-Randomized Confirmatory Trial of Laparoscopy-Assisted Total Gastrectomy and Proximal Gastrectomy with Nodal Dissection for Clinical Stage I Gastric Cancer: Japan Clinical Oncology Group Study JCOG1401
por: Kataoka, Kozo, et al.
Publicado: (2016)

Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-4aN0-3 gastric cancer patients (JCOG1907, MONA LISA study): a study protocol
por: Makuuchi, Rie, et al.
Publicado: (2023)

Tackling the Pharmaceutical Frontier: Regulation of Cannabinoid-Based Medicines in Postwar Japan
por: Miyaji, Tempei, et al.
Publicado: (2016)

Risk factors for early postoperative complications after D3 dissection for stage II or III colon cancer: Supplementary analysis of a multicenter randomized controlled trial in Japan (JCOG0404)
por: Nishizawa, Yusuke, et al.
Publicado: (2019)

Transitional impact of short‐ and long‐term outcomes of a randomized controlled trial to evaluate laparoscopic versus open surgery for colorectal cancer from Japan Clinical Oncology Group Study JCOG0404
por: Fujii, Shoichi, et al.
Publicado: (2019)

A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical oncology group study JCOG1910 (AgedGlio-PIII)
por: Arakawa, Yoshiki, et al.
Publicado: (2021)

Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)
por: Tahara, Makoto, et al.
Publicado: (2015)

Impact of laparoscopy on the prevention of pulmonary complications after thoracoscopic esophagectomy using data from JCOG0502: a prospective multicenter study
por: Nozaki, Isao, et al.
Publicado: (2017)

Clinical impact of D3 lymph node dissection with left colic artery (LCA) preservation compared to D3 without LCA preservation: Exploratory subgroup analysis of data from JCOG0404
por: Akagi, Tomonori, et al.
Publicado: (2020)

Assessment of Cancer-Related Fatigue, Pain, and Quality of Life in Cancer Patients at Palliative Care Team Referral: A Multicenter Observational Study (JORTC PAL-09)
por: Iwase, Satoru, et al.
Publicado: (2015)

Randomized phase III study of daratumumab versus bortezomib plus daratumumab as maintenance therapy after D-MPB for transplant-ineligible patients with untreated multiple myeloma (JCOG1911, B-DASH study)
por: Suzuki, Tomotaka, et al.
Publicado: (2022)

A randomized controlled trial comparing primary tumour resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 (iPACS study)
por: Moritani, Konosuke, et al.
Publicado: (2019)

Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303)
por: Shinoda, Masayuki, et al.
Publicado: (2015)

Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial
por: Kiyota, Naomi, et al.
Publicado: (2022)

Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1)
por: Nakamura, Nobuhiko, et al.
Publicado: (2021)

J‐SUPPORT research policy for oral mucositis associated with cancer treatment
por: Yokota, Tomoya, et al.
Publicado: (2022)

A randomized controlled trial comparing perioperative vs. postoperative mFOLFOX6 for lower rectal cancer with suspected lateral pelvic lymph node metastasis (JCOG1310): a phase II/III randomized controlled trial
por: Ohue, Masayuki, et al.
Publicado: (2022)

Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C
por: Mishima, Kazuhiko, et al.
Publicado: (2022)

The clinical use of Kampo medicines (traditional Japanese herbal treatments) for controlling cancer patients’ symptoms in Japan: a national cross-sectional survey
por: Iwase, Satoru, et al.
Publicado: (2012)

Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema
por: Shiraya, Tomoyasu, et al.
Publicado: (2017)

Research policy in supportive care and palliative care for cancer dyspnea
por: Matsuda, Yoshinobu, et al.
Publicado: (2021)

Optimization of smartphone psychotherapy for depression and anxiety among patients with cancer using the multiphase optimization strategy (MOST) framework and decentralized clinical trial system (SMartphone Intervention to LEssen depression/Anxiety and GAIN resilience: SMILE AGAIN project): a protocol for a randomized controlled trial
por: Uchida, Megumi, et al.
Publicado: (2023)

Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial
por: Kanemitsu, Yukihide, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_meic1pi51rmrfgf1ffba40sg35